A subgroup analysis of the MONICA study: a 12-month, open-label study of add-on montelukast treatment in asthma patients (vol 47, pg 986, 2010)

被引：0
|
作者：
Virchow, J. Christian
机构：
来源：
JOURNAL OF ASTHMA | 2011年 / 48卷 / 06期
关键词：
D O I：
10.3109/02770903.2011.589639
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：650 / 652
页数：3
相关论文
共 50 条
  • [21] Ozone Therapy as Add-On Treatment in Fibromyalgia Management by Rectal Insufflation: An Open-Label Pilot Study
    Hidalgo-Tallon, Javier
    Menendez-Cepero, Silvia
    Vilchez, Juan S.
    Rodriguez-Lopez, Carmen M.
    Calandre, Elena P.
    JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2013, 19 (03) : 238 - 242
  • [22] PERSISTENCE OF SOLIFENACIN TREATMENT IN OVERACTIVE BLADDER PATIENTS IN REAL LIFE PRACTICE: A 12-MONTH, PROSPECTIVE, MULTICENTER, OPEN-LABEL, OBSERVATIONAL STUDY
    Lee, K.
    Lee, Y.
    Chung, J. W.
    Lee, S. H.
    Moon, K. H.
    Jung, H. C.
    Choi, S.
    Choo, M.
    NEUROUROLOGY AND URODYNAMICS, 2012, 31 (06) : 874 - 875
  • [23] PERSISTENCE OF SOLIFENACIN TREATMENT IN OVERACTIVE BLADDER PATIENTS IN REAL LIFE PRACTICE: A 12-MONTH, PROSPECTIVE, MULTICENTER, OPEN-LABEL, OBSERVATIONAL STUDY
    Lee, Young-Suk
    Lee, Kyu-Sung
    Jeong, Jeongyun
    Choo, Myung-Soo
    Kim, Joon Chul
    Seo, Ju Tae
    Choi, Jong Bo
    NEUROUROLOGY AND URODYNAMICS, 2013, 32 (02) : 118 - 119
  • [24] Evaluation of 3-5 months' add-on therapy with montelukast in patients with non-controlled asthma in Austria: the STAR open-label, real-world, observational study
    Schlick, Werner
    Pohl, Wolfgang
    Pfeiffer, Karl P.
    Aigner, Kurt
    Forche, Guenter
    Kneussl, Meinhard
    Zwick, Hartmut
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (03) : 561 - 570
  • [25] Effect of heart failure reversal treatment as add-on therapy in patients with chronic heart failure: A randomized, open-label study
    Sane, R. M.
    Mandole, R.
    Aklujkar, A.
    Patil, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 587 - 588
  • [26] Prospective, open-label, long-term study on levetiracetam add-on treatment in patients with refractory partial epilepsy.
    Boero, G
    Specchio, N
    Stuppiello, M
    Papantonio, A
    De Agazio, G
    De Palo, A
    Sinisi, V
    Santosabato, M
    La Neve, A
    Specchio, LM
    EPILEPSIA, 2004, 45 : 140 - 141
  • [27] Frovatriptan for the prevention of menstrual migraine headaches: Results of a 12-month open-label safety and tolerability study
    Gammaitoni, A
    Ford, C
    Tobin, J
    Shaw, R
    Campbell, J
    NEUROLOGY, 2006, 66 (05) : A224 - A224
  • [28] Juvederm (R) Volbella (TM) in the perioral area: a 12-month prospective, multicenter, open-label study
    Eccleston, David
    Murphy, Diane K.
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2012, 5 : 167 - 172
  • [29] Malar Augmentation With a Polymethylmethacrylate-Enhanced Filler: Assessment of a 12-Month Open-Label Pilot Study
    Mills, Daniel C.
    Camp, Steven
    Mosser, Scott
    Sayeg, Ayoub
    Hurwitz, Dennis
    Ronel, Daniel
    AESTHETIC SURGERY JOURNAL, 2013, 33 (03) : 421 - 430
  • [30] A 12-Month Randomized, Open-Label Study of the Metabolic Effects of Olanzapine and Risperidone in Psychotic Patients: Influence of Valproic Acid Augmentation
    Meltzer, Herbert Y.
    Bonaccorso, Stefania
    Bobo, William V.
    Chen, Yuejin
    Jayathilake, Karuna
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (12) : 1602 - 1610
12345